Experimental drug tested for Hard-to-Treat bowel disease
NCT ID NCT06137183
Summary
This study tested an experimental drug called vixarelimab in people with moderate to severe ulcerative colitis who hadn't responded well to other treatments. The trial aimed to see if the drug could reduce bowel inflammation and symptoms over 12 weeks, and then explore longer-term effects. The study was terminated early and involved 79 participants across multiple medical centers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Institute, Inc.
New Port Richey, Florida, 34653, United States
-
Allmedica Badania Kliniczne sp. z o.o. sp.k.
Nowy Targ, 34-400, Poland
-
Atlanta Gastroenterology Associates
Atlanta, Georgia, 30342, United States
-
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi-Via Massarenti
Bologna, Emilia-Romagna, 40138, Italy
-
CHU de Nancy-Hopital Brabois Adulte
Vandœuvre-lès-Nancy, 54511, France
-
CHU de Saint-Etienne - Hopital Nord
Saint-Etienne, 42055, France
-
Carolina Digestive Diseases
Greenville, North Carolina, 27834, United States
-
Centro Medico Clinico Quirurgico Especializado en Investigacion
Tlajomulco de Zúñiga, Jalisco, 45645, Mexico
-
Centro de Estudos Clinicos do Interior Paulista
Jaú, São Paulo, 17201-130, Brazil
-
Centrum Medyczne Euromedis Sp. z o.o.
Sopot, Pomeranian Voivodeship, 81-756, Poland
-
Centrum Medyczne UNO-MED-Tarnow
Tarnów, 33-100, Poland
-
Centrum Zdrowia MDM
Warsaw, 00-635, Poland
-
China Medical University Hospital
Taichung, 40447, Taiwan
-
Cliagen Clinica de Atençao em Gastroenterologia, Especialidades e Nutriçao
Salvador, Estado de Bahia, 41500-300, Brazil
-
Clinical Applications Laboratories, Inc.
San Diego, California, 92103-5639, United States
-
Clinical Hospital Center Zvezdara
Belgrade, 11000, Serbia
-
Clinical Trials UMED Sp. z o. o.
?ód?, 92-213, Poland
-
Delta Gastroenterology & Endoscopy Center
Southaven, Mississippi, 38671, United States
-
Endohope klinika s. r.o.
Prague, 150 00, Czechia
-
EuroMediCare Szpital Specjalistyczny z Przychodni? we Wroc?awiu
Wroclaw, Lower Silesian Voivodeship, 54-144, Poland
-
Evangelismos General Hospital of Athens
Athens, Attica, 106 76, Greece
-
Facey Medical Foundation - Mission Hills
Mission Hills, California, 91345 1116, United States
-
Fondazione Policlinico Universitario A Gemelli-Rome
Rome, Lazio, 00168, Italy
-
Gastro Intestinal Research Institute of Northern Ohio
Westlake, Ohio, 44145, United States
-
General Hospital Djordje Joanovic - Zrenjanin
Zrenjanin, 23000, Serbia
-
Henry Ford Health System
Novi, Michigan, 48377, United States
-
Hepato-Gastroenterologie HK, s.r.o.
Hradec Králové, 500 12, Czechia
-
Hospital de Clinicas de Porto Alegre HCPA PPDS
Pôrto Alegre, Pará, 90035-903, Brazil
-
Hôpital L'archet 2
Nice, Alpes-Maritimes, 06202, France
-
Iatriko Palaiou Falirou
Palaió Fáliro, 175 62, Greece
-
Inje university Haeundae Paik Hospital
Busan, 48108, South Korea
-
Istituto Clinico Humanitas
Rozzano, Lombardy, 20089, Italy
-
Jinhua municipal central hospital
Jinhua, 321000, China
-
Kaiser Hospital Dia
São José do Rio Preto, São Paulo, 15015-110, Brazil
-
Kangbuk Samsung Hospital
Seoul, 03181, South Korea
-
L2 Ip - Instituto de Pesquisas Clinicas Ltda - ME
Brasília, Federal District, 70200-730, Brazil
-
MZ Badania Slowik Zymla Sp.j.
Knurów, 44-190, Poland
-
Mayo Clinic - PPDS
Rochester, Minnesota, 55905, United States
-
Medical Care & Research SA de CV
Mérida, Yucatán, 97070, Mexico
-
Medical Center Kermed
Bydgoszcz, 85-231, Poland
-
Military Medical Academy
Belgrade, 11000, Serbia
-
NZOZ FORMED sp zo.o.
Wadowice, 34-100, Poland
-
OM Research LLC - Camarillo - ClinEdge - PPDS
Camarillo, California, 93012, United States
-
Office of Jaroslaw Kierkus, Dr n Med
Otwock, 05-400, Poland
-
Orlando Gastroenterology, P.A.
Orlando, Florida, 32835, United States
-
Ospedale San Raffaele S.r.l. - PPDS
Milan, Lombardy, 20132, Italy
-
Pesquisare Saude
Santo André, São Paulo, 09080-110, Brazil
-
PlanetMed
Wroc?aw, 52-210, Poland
-
PreventaMed s.r.o.
Olomouc, 779 00, Czechia
-
Przychodnia VISTAMED
Wroc?aw, 53-149, Poland
-
Renmin Hospital of Wuhan University
Wuhan, 430060, China
-
Sonomed Sp. z o.o.
Szczecin, 71-685, Poland
-
SurGal Clinic s.r.o.
Brno, 602 00, Czechia
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
The Catholic University of Korea Daejeon ST. Mary?s Hospital
Daejeon, 34943, South Korea
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Ningbo University(Ningbo First Hospital)
Ningbo, 315000, China
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, 510080, China
-
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, 510655, China
-
Topolowa Medicenter Mrozek & Wspolnicy Spolka Jawna
Krakow, 31-506, Poland
-
Tyler Research Institute, LLC
Tyler, Texas, 75701, United States
-
UCLA Clinical and Translational Research Center
Los Angeles, California, 90095, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, 430023, China
-
University of Utah - Health Sciences Center - PPDS
Salt Lake City, Utah, 84132, United States
-
Yonsei University Wonju Severance Christian Hospital
Gangwon-do, 26426, South Korea
Conditions
Explore the condition pages connected to this study.